Answers are grounded in this paper and cite their sources.
Whether technological advances have the potential to transform skin cancer diagnosis has gained considerable interest, particularly in countries such as the UK and USA, where the incidence of skin cancers is rising. Although skin cancers are common, especially the keratinocyte cancers (such as basal cell carcinoma and squamous cell carcinoma), these cancers can be challenging for patients and doctors to differentiate from benign lesions. Therefore, patients might present late, primary health-care professionals might refer or excise lesions too readily, and there might not be enough dermatologists available to triage the numbers of patients with suspicious lesions to provide diagnosis and treatment or reassurance.
No takes yet. Share an insight, caveat, or question.
Walter et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: